Noninvasive imaging of experimental lung fibrosis

American Journal of Respiratory Cell and Molecular Biology

Volumn 53, Issue 1, 2015, Pages 8-13

  Zhou, Yong ^a   Chen, Huaping ^a   Ambalavanan, Namasivayam ^b   Liu, Gang ^a   Antony, Veena B ^a   Ding, Qiang ^a   Nath, Hrudaya ^c   Eary, Janet F ^c   Thannickal, Victor J ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Lung fibrosis; Micro CT; MRI; Nuclear imaging; Small animal models

Indexed keywords

FLUORODEOXYGLUCOSE F 18; PROLINE; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG; XENON; XENON 129;

ANIMAL MODEL; CELL SURFACE; CLINICAL EVALUATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONE BEAM COMPUTED TOMOGRAPHY; EXPERIMENTAL PULMONARY FIBROSIS; GLUCOSE METABOLISM; LUNG INJURY; MICRO-COMPUTED TOMOGRAPHY; MOLECULAR IMAGING; MULTIMODAL IMAGING; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PROTON RADIATION; RADIATION EXPOSURE; RADIATION INJURY; RESPIRATORY GATED IMAGING; REVIEW; SELF GATED NUCLEAR MAGNETIC RESONANCE IMAGING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX RADIOGRAPHY; THREE DIMENSIONAL IMAGING; ANIMAL; DISEASE MODEL; HUMAN; PROCEDURES; PULMONARY FIBROSIS; RADIOGRAPHY;

ANIMALIA;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; POSITRON-EMISSION TOMOGRAPHY; PULMONARY FIBROSIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; X-RAY MICROTOMOGRAPHY;

EID: 84937002221     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2015-0032TR     Document Type: Review

References (43)

1. Gammon ST, Foje N, Brewer EM, Owers E, Downs CA, Budde MD, Leevy WM, Helms MN. Preclinical anatomical, molecular, and functional imaging of the lung with multiple modalities. Am J Physiol Lung Cell Mol Physiol 2014;306:L897-L914.
2. Cavanaugh D, Travis EL, Price RE, Gladish G, White RA, Wang M, Cody DD. Quantification of bleomycin-induced murine lung damage in vivo with micro-computed tomography. Acad Radiol 2006;13:1505-1512.
3. De Langhe E, Vande Velde G, Hostens J, Himmelreich U, Nemery B, Luyten FP, Vanoirbeek J, Lories RJ. Quantification of lung fibrosis and emphysema in mice using automated micro-computed tomography. PLoS One 2012;7:e43123.
4. Scotton CJ, Hayes B, Alexander R, Datta A, Forty EJ, Mercer PF, Blanchard A, Chambers RC. Ex vivo micro-computed tomography analysis of bleomycin-induced lung fibrosis for preclinical drug evaluation. Eur Respir J 2013;42:1633-1645.
5. Rodt T, von Falck C, Dettmer S, Halter R, Maus R, Ask K, Kolb M, Gauldie J, La¨nger F, Hoy L, et al. Micro-computed tomography of pulmonary fibrosis in mice induced by adenoviral gene transfer of biologically active transforming growth factor-β1. Respir Res 2010;11:181.
6. Shofer S, Badea C, Auerbach S, Schwartz DA, Johnson GA. A microcomputed tomography-based method for the measurement of pulmonary compliance in healthy and bleomycin-exposed mice. Exp Lung Res 2007;33:169-183.
7. Ask K, Labiris R, Farkas L, Moeller A, Froese A, Farncombe T, McClelland GB, Inman M, Gauldie J, Kolb MR. Comparison between conventional and "clinical" assessment of experimental lung fibrosis. J Transl Med 2008;6:16.
8. Cavanaugh D, Johnson E, Price RE, Kurie J, Travis EL, Cody DD. In vivo respiratory-gated micro-CT imaging in small-animal oncology models. Mol Imaging 2004;3:55-62.
9. Johnston SM, Perez BA, Kirsch DG, Badea CT. Phase-selective image reconstruction of the lungs in small animals using micro-ct. Proc Soc Photo Opt Instrum Eng 2010;7622:76223G.76221-76223G.76229.
10. Greschus S, Kiessling F, Lichy MP, Moll J, Mueller MM, Savai R, Rose F, Ruppert C, Günther A, Luecke M, et al. Potential applications of flat-panel volumetric CT in morphologic and functional small animal imaging. Neoplasia 2005;7:730-740.
11. Detombe SA, Dunmore-Buyze J, Petrov IE, Drangova M. X-ray dose delivered during a longitudinal micro-CT study has no adverse effect on cardiac and pulmonary tissue in C57BL/6 mice. Acta Radiol 2013;54:435-441.
12. Day RM, Barshishat-Kupper M, Mog SR, McCart EA, Prasanna PG, Davis TA, Landauer MR. Genistein protects against biomarkers of delayed lung sequelae in mice surviving high-dose total body irradiation. J Radiat Res (Tokyo) 2008;49:361-372.
13. Beckmann F, Bonse U, Busch F, Günnewig O. X-ray microtomography (microCT) using phase contrast for the investigation of organic matter. J Comput Assist Tomogr 1997;21:539-553.
14. Karmouty-Quintana H, Cannet C, Zurbruegg S, Blé FX, Fozard JR, Page CP, Beckmann N. Bleomycin-induced lung injury assessed noninvasively and in spontaneously breathing rats by proton MRI. J Magn Reson Imaging 2007;26:941-949.
15. Ohno Y, Koyama H, Yoshikawa T, Nishio M, Matsumoto S, Iwasawa T, Sugimura K. Pulmonary magnetic resonance imaging for airway diseases. J Thorac Imaging 2011;26:301-316.
16. Egger C, Cannet C, Gérard C, Jarman E, Jarai G, Feige A, Suply T, Micard A, Dunbar A, Tigani B, et al. Administration of bleomycin via the oropharyngeal aspiration route leads to sustained lung fibrosis in mice and rats as quantified by UTE-MRI and histology. PLoS One 2013;8:e63432.
17. Hedlund LW, Cofer GP, Owen SJ, Allan Johnson G. MR-compatible ventilator for small animals: computer-controlled ventilation for proton and noble gas imaging. Magn Reson Imaging 2000;18:753-759.
18. Jones KM, Randtke EA, Howison CM, Cárdenas-Rodríguez J, Sime PJ, Kottmann MR, Pagel MD. Measuring extracellular ph in a lung fibrosis model with acidoCEST MRI. Mol Imaging Biol (In press)
19. van Heeswijk RB, Bonanno G, Coppo S, Coristine A, Kober T, Stuber M. Motion compensation strategies in magnetic resonance imaging. Crit Rev Biomed Eng 2012;40:99-119.
20. Vande Velde G, De Langhe E, Poelmans J, Dresselaers T, Lories RJ, Himmelreich U. Magnetic resonance imaging for noninvasive assessment of lung fibrosis onset and progression: cross-validation and comparison of different magnetic resonance imaging protocols with micro-computed tomography and histology in the bleomycin-induced mouse model. Invest Radiol 2014;49:691-698.
21. Beckmann N, Tigani B, Mazzoni L, Fozard JR. MRI of lung parenchyma in rats and mice using a gradient-echo sequence. NMR Biomed 2001;14:297-306.
22. 129Xe MRI. Proc Natl Acad Sci USA 2006;103:18278-18283.
23. Stephen MJ, Emami K, Woodburn JM, Chia E, Kadlecek S, Zhu J, Pickup S, Ishii M, Rizi RR, Rossman M. Quantitative assessment of lung ventilation and microstructure in an animal model of idiopathic pulmonary fibrosis using hyperpolarized gas MRI. Acad Radiol 2010;17:1433-1443.
24. Ward ER, Hedlund LW, Kurylo WC, Wheeler CT, Cofer GP, Dewhirst MW, Marks LB, Vujaskovic Z. Proton and hyperpolarized helium magnetic resonance imaging of radiation-induced lung injury in rats. Int J Radiat Oncol Biol Phys 2004;58:1562-1569.
25. Berthezène Y, Vexler V, Kuwatsuru R, Rosenau W, Mühler A, Clément O, Price DC, Brasch RC. Differentiation of alveolitis and pulmonary fibrosis with a macromolecular MR imaging contrast agent. Radiology 1992;185:97-103.
26. Kersjes W, Hildebrandt G, Cagil H, Schunk K, von Zitzewitz H, Schild H. Differentiation of alveolitis and pulmonary fibrosis in rabbits with magnetic resonance imaging after intrabronchial administration of bleomycin. Invest Radiol 1999;34:13-21.
27. Taylor CR, Sostman HD, Gore JC, Smith GW. Proton relaxation times in bleomycin-induced lung injury. Invest Radiol 1987;22:621-626.
28. Cutillo AG, Chan PH, Ailion DC, Watanabe S, Rao NV, Hansen CB, Albertine KH, Laicher G, Durney CH. Characterization of bleomycin lung injury by nuclear magnetic resonance: correlation between NMR relaxation times and lung water and collagen content. Magn Reson Med 2002;47:246-256.
29. Yi CA, Lee KS, Han J, Chung MP, Chung MJ, Shin KM. 3-T MRI for differentiating inflammation- and fibrosis-predominant lesions of usual and nonspecific interstitial pneumonia: comparison study with pathologic correlation. AJR Am J Roentgenol 2008;190:878-885.
30. Babin AL, Cannet C, Gérard C, Wyss D, Page CP, Beckmann N. Noninvasive assessment of bleomycin-induced lung injury and the effects of short-term glucocorticosteroid treatment in rats using MRI. J Magn Reson Imaging 2011;33:603-614.
31. Jacob RE, Amidan BG, Soelberg J, Minard KR. In vivo MRI of altered proton signal intensity and T2 relaxation in a bleomycin model of pulmonary inflammation and fibrosis. J Magn Reson Imaging 2010;31:1091-1099.
32. Jones HA, Schofield JB, Krausz T, Boobis AR, Haslett C. Pulmonary fibrosis correlates with duration of tissue neutrophil activation. Am J Respir Crit Care Med 1998;158:620-628.
33. Win T, Lambrou T, Hutton BF, Kayani I, Screaton NJ, Porter JC, Maher TM, Endozo R, Shortman RI, Lukey P, et al. 18F-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: implications for future clinical trials. Eur J Nucl Med Mol Imaging 2012;39:521-528.
34. Jones HA, Hamacher K, Clark JC, Schofield JB, Krausz T, Haslett C, Boobis AR. Positron emission tomography in the quantification of cellular and biochemical responses to intrapulmonary particulates. Toxicol Appl Pharmacol 2005;207(Suppl):230-236.
35. Fireman E, Shahar I, Shoval S, Messer G, Dvash S, Grief J. Morphological and biochemical properties of alveolar fibroblasts in interstitial lung diseases. Lung 2001;179:105-117.
36. Groves AM, Win T, Screaton NJ, Berovic M, Endozo R, Booth H, Kayani I, Menezes LJ, Dickson JC, Ell PJ. Idiopathic pulmonary fibrosis and diffuse parenchymal lung disease: implications from initial experience with 18F-FDG PET/CT. J Nucl Med 2009;50:538-545.
37. Wester HJ, Herz M, Senekowitsch-Schmidtke R, Schwaiger M, Stöcklin G, Hamacher K. Preclinical evaluation of 4-[18F]fluoroprolines: diastereomeric effect on metabolism and uptake in mice. Nucl Med Biol 1999;26:259-265.
38. 18F]fluoro-L-proline PET imaging of pulmonary fibrosis in a rabbit model. J Nucl Med 2002;43:413-420.
39. Borie R, Fabre A, Prost F, Marchal-Somme J, Lebtahi R, Marchand-Adam S, Aubier M, Soler P, Crestani B. Activation of somatostatin receptors attenuates pulmonary fibrosis. Thorax 2008;63:251-258.
40. Antunes P, Ginj M, Zhang H, Waser B, Baum RP, Reubi JC, Maecke H. Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? Eur J Nucl Med Mol Imaging 2007;34:982-993.
41. Ambrosini V, Zompatori M, De Luca F, Antonia D, Allegri V, Nanni C, Malvi D, Tonveronachi E, Fasano L, Fabbri M, et al. 68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results. J Nucl Med 2010;51:1950-1955.
42. Pettinato C, Sarnelli A, Di Donna M, Civollani S, Nanni C, Montini G, Di Pierro D, Ferrari M, Marengo M, Bergamini C. 68Ga-DOTANOC: biodistribution and dosimetry in patients affected by neuroendocrine tumors. Eur J Nucl Med Mol Imaging 2008;35:72-79.
43. John AE, Luckett JC, Tatler AL, Awais RO, Desai A, Habgood A, Ludbrook S, Blanchard AD, Perkins AC, Jenkins RG, et al. Preclinical SPECT/CT imaging of αvβ6 integrins for molecular stratification of idiopathic pulmonary fibrosis. J Nucl Med 2013;54:2146-2152.